PLYMOUTH TOWNSHIP — Delphinus Medical Technologies Inc. has named Ronald Ho to its board of directors.
Ho’s accomplished career has included multiple executive positions spanning over 20 years within the medical imaging industry, predominantly in ultrasound. He was president and chief executive officer of U-Systems, developer of an automated whole breast ultrasound system. During his tenure, the company achieved the first and only FDA approval for a breast ultrasound screening indication. Following this, Ho directed U-Systems through the strategic and successful acquisition by GE Healthcare.
Delphinus is the first company to design and manufacture a breast ultrasound system that utilizes ring transducer technology to transmit and receive ultrasound signals. SoftVue captures reflection echoes from all directions around the breast and gathers transmitted signals coming through the breast. With a short scan time of one to two minutes per breast, SoftVue presents a complete image map of the whole breast, providing a consistent and uniform exam without reliance on operator skill and technique.
